Search results
Should We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?
Simply Wall St. via Yahoo Finance Canada· 2 days agoWe'll use ROE to examine GSK plc (LON:GSK), by way of a worked example. Return on Equity or ROE is a...
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Zacks via Yahoo Finance Canada· 2 days agoGSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration...
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Zacks via Yahoo Finance Canada· 2 days agoThis is the second time that the FDA has requested additional information from the company on...
GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots
Bloomberg· 3 days agoHave a confidential tip for our reporters? GSK Plc agreed to pay as much as €1.4 billion ($1.5...
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Digital Journal· 3 days agoGSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinationsCureVac receives €400 ...
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Zacks via Yahoo Finance Canada· 5 days agoModerna’s stock also took a hit last week after it presented new data on mResvia to the CDC, which...
Bioz Brings Cutting-Edge AI Citation Widgets to Precision X-Ray, Inc.'s Product Pages
Digital Journal· 3 days ago...Cultural Series Redefines AI & Visual Art in Mykonos & Bodrum GSK and CureVac to Restructure Collaboration into New Licensing Agreement...Value mRNA Pipeline Opportunities InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 3 'Port of Hueneme Cares...
US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms
Bloomberg via Yahoo Finance Canada· 4 days ago(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development...
Drugmakers Resist FTC, Lawmaker Efforts to Remove Drug Patents
Bloomberg Law· 5 days agoMajor pharmaceutical companies are resisting calls from the Biden administration and Democratic lawmakers to curb patenting practices on high-cost drugs, putting pressure on the federal government ...
Increasing Demand Customized Treatment is likely to Boost Necrotizing Fasciitis Treatment Market...
Digital Journal· 3 days agoNecrotizing Fasciitis Treatment Industry is Expected to Reach USD 4.5 Billion by 2034 And Grow at A CAGR of 5.2%. NEWARK, DE / ACCESSWIRE / July 3, 2024 / The necrotizing fasciitis treatment ...